{"id":"placebo-equivalent","safety":{"commonSideEffects":[{"rate":null,"effect":"Placebo response (symptom improvement without active ingredient)"}]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo equivalent","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:59:22.909892+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:59:29.626361+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo equivalent","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:59:30.285286+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inactive substances or procedures designed to mimic active treatments without containing any therapeutically active ingredients. They are used primarily in clinical trials to establish baseline efficacy through comparison with active drugs, and can produce measurable clinical benefits through psychobiological mechanisms including expectation and conditioning effects.","oneSentence":"A placebo equivalent produces no pharmacological effect and serves as an inert control in clinical research and therapeutic contexts.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:08.673Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:59:32.585438+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Clinical trial control comparator (non-therapeutic use)"}]},"trialDetails":[{"nctId":"NCT06972446","phase":"PHASE2","title":"A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-06-20","conditions":"Rheumatoid Arthritis","enrollment":180},{"nctId":"NCT07008586","phase":"NA","title":"The Impact of OliPhenolia® Supplementation on Exercise Induced Inflammation and Functional Movement in Humans.","status":"COMPLETED","sponsor":"Anglia Ruskin University","startDate":"2025-07-01","conditions":"Healthy","enrollment":18},{"nctId":"NCT05556824","phase":"PHASE2","title":"Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Microbiome Health Sciences","startDate":"2023-03-03","conditions":"Gastroesophageal Reflux","enrollment":247},{"nctId":"NCT06337838","phase":"PHASE3","title":"Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-09","conditions":"Chronic Kidney Diseases, Acute Kidney Injury, Bleeding","enrollment":100},{"nctId":"NCT04534556","phase":"NA","title":"Wireless Nerve Stimulation Device To Enhance Recovery After Stroke","status":"RECRUITING","sponsor":"Baylor Research Institute","startDate":"2021-09-01","conditions":"Stroke, Chronic Stroke, Upper Extremity Paresis","enrollment":42},{"nctId":"NCT05075824","phase":"PHASE2","title":"A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-03-09","conditions":"Sickle Cell Disease","enrollment":90},{"nctId":"NCT07488832","phase":"NA","title":"Intravenous Lidocaine Infusion in Lumbar Fusion Surgery","status":"NOT_YET_RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-03-20","conditions":"Lumbar Fusion Surgery","enrollment":110},{"nctId":"NCT06909565","phase":"PHASE4","title":"Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-07-23","conditions":"Percutaneous Coronary Intervention, Peripheral Endovascular Intervention","enrollment":6000},{"nctId":"NCT07224711","phase":"PHASE4","title":"The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2026-07-01","conditions":"Pain, Post Operative Analgesia, Opioid Consumption, Postoperative","enrollment":2290},{"nctId":"NCT06468228","phase":"PHASE3","title":"A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-06-27","conditions":"Hidradenitis Suppurativa","enrollment":1280},{"nctId":"NCT06040086","phase":"PHASE3","title":"Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2023-09-22","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1454},{"nctId":"NCT07426640","phase":"NA","title":"Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation","status":"COMPLETED","sponsor":"Al Mouwasat Hospital","startDate":"2021-11-01","conditions":"Premature (Early) Ejaculation","enrollment":150},{"nctId":"NCT03100149","phase":"PHASE2","title":"A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2017-06-27","conditions":"Parkinson's Disease","enrollment":316},{"nctId":"NCT04512235","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-11-03","conditions":"AL Amyloidosis","enrollment":281},{"nctId":"NCT04504825","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-08-25","conditions":"AL Amyloidosis","enrollment":125},{"nctId":"NCT05402332","phase":"PHASE2","title":"Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801)","status":"NOT_YET_RECRUITING","sponsor":"Eva Morava-Kozicz","startDate":"2026-10-01","conditions":"PGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of Glycosylation","enrollment":8},{"nctId":"NCT05065424","phase":"PHASE4","title":"Premedication for Less Invasive Surfactant Administration Study (PRELISA)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-04-06","conditions":"Respiratory Distress Syndrome, Newborn","enrollment":58},{"nctId":"NCT06901297","phase":"PHASE3","title":"The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients","status":"RECRUITING","sponsor":"Materia Medica Holding","startDate":"2025-04-03","conditions":"Rhinosinusitis, Rhinosinusitis Acute","enrollment":552},{"nctId":"NCT05739383","phase":"PHASE3","title":"A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-03-09","conditions":"Primary Prevention of Atherosclerotic Cardiovascular Disease","enrollment":14078},{"nctId":"NCT05742802","phase":"PHASE3","title":"Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2023-03-06","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1713},{"nctId":"NCT04666610","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy","status":"ACTIVE_NOT_RECRUITING","sponsor":"UCB Biopharma SRL","startDate":"2021-07-29","conditions":"Childhood Absence Epilepsy, Juvenile Absence Epilepsy","enrollment":153},{"nctId":"NCT05664477","phase":"PHASE2","title":"PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition","status":"ACTIVE_NOT_RECRUITING","sponsor":"Roberta Brinton","startDate":"2024-01-10","conditions":"Menopause, Cognitive Change, Brain Disorder, Metabolic","enrollment":100},{"nctId":"NCT06715891","phase":"PHASE3","title":"Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years","status":"RECRUITING","sponsor":"Materia Medica Holding","startDate":"2024-11-11","conditions":"Acute Respiratory Viral Infection","enrollment":374},{"nctId":"NCT07020832","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation","status":"RECRUITING","sponsor":"Apellis Pharmaceuticals, Inc.","startDate":"2026-02","conditions":"Delayed Graft Function, End Stage Renal Disease, Deceased Donor Kidney Transplant","enrollment":320},{"nctId":"NCT07470021","phase":"NA","title":"Preop US-Guided Nerve Blocks for Pain & Recovery After Ankle Arthroscopy","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-01-30","conditions":"Ankle Ligament Injury，Chronic Ankle Instability，Ankle Arthroscopy","enrollment":70},{"nctId":"NCT06365892","phase":"NA","title":"Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":64},{"nctId":"NCT05379634","phase":"PHASE2","title":"A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-07-05","conditions":"Myositis","enrollment":36},{"nctId":"NCT07466485","phase":"PHASE2","title":"The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)","status":"RECRUITING","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2026-03-02","conditions":"Alcoholic Fatty Liver Disease","enrollment":26},{"nctId":"NCT03451851","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2018-07-11","conditions":"Psoriasis","enrollment":120},{"nctId":"NCT07464691","phase":"NA","title":"Effect of Prebiotics in Saudi Adults With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Princess Nourah Bint Abdulrahman University","startDate":"2026-09-13","conditions":"Type 2 Diabetes, Metabolic Health, Inflammation","enrollment":100},{"nctId":"NCT07464249","phase":"NA","title":"Comparison of the Effectiveness of Different Diuretic Therapies in the Management of Acute Heart Failure","status":"COMPLETED","sponsor":"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey","startDate":"2024-04-03","conditions":"Acute Decompensated Heart Failure (ADHF)","enrollment":50},{"nctId":"NCT06901531","phase":"PHASE3","title":"A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer","status":"RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2025-05-22","conditions":"Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer","enrollment":500},{"nctId":"NCT02521311","phase":"PHASE2","title":"Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2017-02-28","conditions":"Optic Neuritis","enrollment":90},{"nctId":"NCT03142568","phase":"PHASE2","title":"Safety of Sildenafil in Premature Infants","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-04-02","conditions":"Bronchopulmonary Dysplasia","enrollment":109},{"nctId":"NCT06897748","phase":"PHASE2","title":"A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2025-04-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":98},{"nctId":"NCT07456670","phase":"PHASE2","title":"Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support","status":"NOT_YET_RECRUITING","sponsor":"Queen's University","startDate":"2026-04-01","conditions":"Preterm Birth, Caffeine, Neonatal Outcomes","enrollment":62},{"nctId":"NCT04495725","phase":"NA","title":"Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain","status":"COMPLETED","sponsor":"Vireo Health","startDate":"2020-10-06","conditions":"Opioid Use, Marijuana, Chronic Pain","enrollment":270},{"nctId":"NCT04218084","phase":"PHASE3","title":"Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease","status":"TERMINATED","sponsor":"Pfizer","startDate":"2020-11-11","conditions":"Sickle Cell Disease","enrollment":236},{"nctId":"NCT05039619","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-05-12","conditions":"Lupus Nephritis","enrollment":40},{"nctId":"NCT06977932","phase":"NA","title":"The Alternative Effects of Electroacupuncture in the Treatment of Trigeminal Neuralgia","status":"NOT_YET_RECRUITING","sponsor":"Yuanyuan Wu","startDate":"2026-03-01","conditions":"Trigeminal Neuralgia","enrollment":126},{"nctId":"NCT05350774","phase":"PHASE2","title":"Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2023-07-10","conditions":"Systemic Inflammation, Neuroinflammation, Microvascular Thrombosis","enrollment":45},{"nctId":"NCT04288245","phase":"NA","title":"Targeted Plasticity Therapy for Upper Limb Rehabilitation in Spinal Cord Injuries","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor Research Institute","startDate":"2021-02-15","conditions":"Spinal Cord Injuries, Upper Extremity Paresis","enrollment":20},{"nctId":"NCT06932263","phase":"PHASE2","title":"Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-26","conditions":"Asthma","enrollment":540},{"nctId":"NCT05407324","phase":"PHASE2","title":"Dazucorilant in Patients With Amyotrophic Lateral Sclerosis","status":"RECRUITING","sponsor":"Corcept Therapeutics","startDate":"2022-11-15","conditions":"Amyotrophic Lateral Sclerosis","enrollment":279},{"nctId":"NCT07035301","phase":"NA","title":"Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures","status":"COMPLETED","sponsor":"Harbin Medical University","startDate":"2025-03-17","conditions":"Disease of Respiratory System","enrollment":153},{"nctId":"NCT07422675","phase":"PHASE1","title":"SAD Study in Patients With Parkinson's Disease and Motor Fluctuations","status":"RECRUITING","sponsor":"Serina Therapeutics","startDate":"2026-02-01","conditions":"PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease","enrollment":40},{"nctId":"NCT06563895","phase":"PHASE3","title":"Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant","status":"RECRUITING","sponsor":"Eidos Therapeutics, a BridgeBio company","startDate":"2025-05-12","conditions":"Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis","enrollment":582},{"nctId":"NCT07172022","phase":"PHASE2","title":"A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)","status":"WITHDRAWN","sponsor":"Hoffmann-La Roche","startDate":"2026-03-16","conditions":"Antiphospholipid Syndrome","enrollment":""},{"nctId":"NCT05144256","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2022-06-08","conditions":"Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia","enrollment":49},{"nctId":"NCT07439744","phase":"NA","title":"NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status","status":"RECRUITING","sponsor":"National Science and Technology Council, Taiwan","startDate":"2025-03-01","conditions":"Obese Adults, MDD","enrollment":50},{"nctId":"NCT07440394","phase":"NA","title":"Evaluation of Pine Bark Extract for Anti-fatigue Ergogenic Properties","status":"COMPLETED","sponsor":"China Medical University Hospital","startDate":"2023-04-21","conditions":"Healthy","enrollment":14},{"nctId":"NCT06624878","phase":"NA","title":"Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer","status":"COMPLETED","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-10-08","conditions":"Ovarian Cancer, Cytoreductive Surgery, Depressive Symptom","enrollment":568},{"nctId":"NCT03153527","phase":"PHASE4","title":"Taper Or Abrupt Steroid Stop: TOASSTtrial","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2017-05-31","conditions":"Inflammatory Disorder, Autoimmune","enrollment":530},{"nctId":"NCT06599697","phase":"PHASE2","title":"The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-10-27","conditions":"Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy","enrollment":12},{"nctId":"NCT07429448","phase":"PHASE1","title":"Comparison Of Clinical Outcomes of Intraperitoneal Bupivacaine Instillation Versus Placebo as Preemptive Analgesia in Patients Undergoing Open Appendectomy","status":"RECRUITING","sponsor":"Sardar Umer Rehman","startDate":"2025-12-16","conditions":"Appendectomy","enrollment":60},{"nctId":"NCT06416462","phase":"NA","title":"Action of Photodynamic Therapy on Wound Quality and Tissue Repair in the Diabetic Foot","status":"COMPLETED","sponsor":"University of Nove de Julho","startDate":"2024-07-30","conditions":"Diabetic Foot Ulcer","enrollment":94},{"nctId":"NCT01821690","phase":"PHASE4","title":"Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression","status":"COMPLETED","sponsor":"Indiana University","startDate":"2013-05-15","conditions":"Traumatic Brain Injury","enrollment":81},{"nctId":"NCT05018585","phase":"PHASE3","title":"A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diamyd Medical AB","startDate":"2022-05-19","conditions":"Type 1 Diabetes Mellitus","enrollment":330},{"nctId":"NCT07312851","phase":"PHASE1","title":"A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-19","conditions":"Healthy Participants","enrollment":186},{"nctId":"NCT06612762","phase":"NA","title":"Naringenin Supplementation in Bone Fracture Patients","status":"RECRUITING","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2024-11-03","conditions":"Bone Fractures","enrollment":70},{"nctId":"NCT06701331","phase":"PHASE3","title":"Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2024-12-22","conditions":"Atopic Dermatitis","enrollment":99},{"nctId":"NCT03694158","phase":"PHASE4","title":"Investigating Dupilumab's Effect in Asthma by Genotype","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2021-09-08","conditions":"Asthma","enrollment":150},{"nctId":"NCT07428070","phase":"NA","title":"Contextually Enriched Individualized Exercise Versus Contextually Fixed Exercise for Rotator Cuff-Related Shoulder Pain","status":"NOT_YET_RECRUITING","sponsor":"Istanbul Nisantasi University","startDate":"2026-04-06","conditions":"Rotator Cuff Related Shoulder Pain, Shoulder Pain, Rotator Cuff Injuries","enrollment":72},{"nctId":"NCT07423000","phase":"PHASE1","title":"A Phase 1 Study of PVT401 in Healthy Subjects","status":"NOT_YET_RECRUITING","sponsor":"Parvus Therapeutics, Inc.","startDate":"2026-04","conditions":"Inflammatory Bowel Disease (IBD)","enrollment":36},{"nctId":"NCT07423910","phase":"NA","title":"PRO-RSTAP: Effect of TAP and RS Blocks on Recovery After Inguinal Hernia Surgery (PRO-RSTAP)","status":"RECRUITING","sponsor":"Tampere University Hospital","startDate":"2025-07-01","conditions":"Inguinal Hernia","enrollment":200},{"nctId":"NCT06008197","phase":"PHASE3","title":"A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients","status":"RECRUITING","sponsor":"Colorado Prevention Center","startDate":"2024-01-17","conditions":"Heart Failure, Acute Heart Failure","enrollment":5200},{"nctId":"NCT03829332","phase":"PHASE3","title":"Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-03-13","conditions":"Non-small Cell Lung Cancer","enrollment":623},{"nctId":"NCT04380740","phase":"PHASE2","title":"Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2022-03-30","conditions":"Graft Vs Host Disease","enrollment":160},{"nctId":"NCT06692764","phase":"PHASE2","title":"A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-10-30","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":202},{"nctId":"NCT03211455","phase":"PHASE3","title":"Intravenous Lidocaine in Bariatric Surgery.","status":"COMPLETED","sponsor":"University Hospital, Caen","startDate":"2017-12-01","conditions":"Morbid Obesity, Bariatric Surgery Candidate","enrollment":180},{"nctId":"NCT03596801","phase":"PHASE1","title":"Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-06-29","conditions":"RSV Infection","enrollment":60},{"nctId":"NCT07405957","phase":"NA","title":"Effects of Two Different Lion's Mane Extracts (Lions Mane Fruiting Body & Lions Mane Fruiting Body With Mycellium) on Cognitive Performance, Subjective Affect, Serum Biomarkers, and Gut Microbiota in Healthy Adults","status":"COMPLETED","sponsor":"Applied Food Sciences Inc.","startDate":"2025-02-11","conditions":"Healthy Adult Females, Healthy Adult Male","enrollment":87},{"nctId":"NCT06525077","phase":"PHASE3","title":"Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Avadel","startDate":"2024-08-01","conditions":"Idiopathic Hypersomnia","enrollment":150},{"nctId":"NCT05233566","phase":"PHASE3","title":"Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-04-25","conditions":"Postoperative Depression","enrollment":32},{"nctId":"NCT06943404","phase":"PHASE2","title":"BXCL501 After Stress to Increase Recovery Success","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-02-11","conditions":"Acute Stress Reaction, Acute Stress Disorder, Post-traumatic Stress Disorder","enrollment":100},{"nctId":"NCT05650645","phase":"PHASE2","title":"The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2023-01-01","conditions":"Tinnitus","enrollment":41},{"nctId":"NCT07231289","phase":"NA","title":"Effect of Soundscapes on Emotional Distress in Fibromyalgia: a 4×4 Crossover Trial","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2025-11-24","conditions":"Fibromyalgia Syndrome","enrollment":72},{"nctId":"NCT07215273","phase":"PHASE2","title":"Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections","status":"RECRUITING","sponsor":"Elion Therapeutics, Inc.","startDate":"2026-02","conditions":"Suspected Invasive Mould Infection","enrollment":80},{"nctId":"NCT04487080","phase":"PHASE3","title":"A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-30","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":1074},{"nctId":"NCT04644029","phase":"PHASE3","title":"Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-02-24","conditions":"HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis","enrollment":730},{"nctId":"NCT05953480","phase":"PHASE2","title":"A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shionogi","startDate":"2023-07-14","conditions":"Acute Ischemic Stroke","enrollment":680},{"nctId":"NCT07384247","phase":"NA","title":"Trigger Point Dry Needling With and Without Electrical Stimulation in Healthy Subjects","status":"COMPLETED","sponsor":"University of Rhode Island","startDate":"2023-01-02","conditions":"People With Identified Painful Trigger Points (Tp) Within the Soleus and Gastrocnemius Muscles Complex, Healthy Subjects or Volunteers","enrollment":40},{"nctId":"NCT05776927","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-05-29","conditions":"Asthma","enrollment":304},{"nctId":"NCT06451757","phase":"PHASE3","title":"KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases","status":"RECRUITING","sponsor":"Khondrion BV","startDate":"2026-02","conditions":"Mitochondrial Diseases, Maternally Inherited Diabetes and Deafness (MIDD), Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)","enrollment":220},{"nctId":"NCT05067127","phase":"PHASE3","title":"Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis","status":"COMPLETED","sponsor":"Apellis Pharmaceuticals, Inc.","startDate":"2021-11-12","conditions":"C3G, IC-MPGN, C3 Glomerulopathy","enrollment":124},{"nctId":"NCT07373106","phase":"NA","title":"Short-term Effects of Broccoli-derived Glucoraphanin on Recovery From Eccentric Muscle Damage","status":"NOT_YET_RECRUITING","sponsor":"Lithuanian Sports University","startDate":"2026-02-15","conditions":"Healthy","enrollment":17},{"nctId":"NCT07373834","phase":"NA","title":"Tirzepatide and Muscle Outcomes in Obesity","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2026-01","conditions":"Obesity (Disorder)","enrollment":30},{"nctId":"NCT04105231","phase":"PHASE2","title":"Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lone Baandrup","startDate":"2021-06-01","conditions":"Dual Diagnosis","enrollment":64},{"nctId":"NCT04851964","phase":"PHASE3","title":"Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-04-22","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":416},{"nctId":"NCT05195918","phase":"PHASE1","title":"Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hal Chapman","startDate":"2023-08-24","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":50},{"nctId":"NCT06265532","phase":"PHASE1","title":"Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hal Chapman","startDate":"2024-02-07","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":22},{"nctId":"NCT05849129","phase":"PHASE2","title":"Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2024-10-01","conditions":"Lung Cancer","enrollment":90},{"nctId":"NCT03818035","phase":"PHASE3","title":"A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2019-02-08","conditions":"Psoriasis","enrollment":880},{"nctId":"NCT04040452","phase":"PHASE4","title":"Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery","status":"RECRUITING","sponsor":"Phoenix Children's Hospital","startDate":"2021-03-01","conditions":"Congenital Heart Disease in Children","enrollment":166},{"nctId":"NCT04897802","phase":"PHASE4","title":"Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2021-09-13","conditions":"Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism","enrollment":42},{"nctId":"NCT07353749","phase":"PHASE4","title":"Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms","status":"NOT_YET_RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2026-01-30","conditions":"Unruptured Intracranial Aneurysms, Cerebrovascular Event, Hemorrhagic Stroke","enrollment":864},{"nctId":"NCT05166889","phase":"PHASE3","title":"Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2022-01-03","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1132},{"nctId":"NCT07347886","phase":"NA","title":"Clinical Outcomes of Sedation in Cataract Surgery Performed Under Topical Anesthesia","status":"NOT_YET_RECRUITING","sponsor":"Istanbul University - Cerrahpasa","startDate":"2026-01","conditions":"Cataract","enrollment":120},{"nctId":"NCT07348159","phase":"NA","title":"Effect of Nalbuphine on Hemodynamic Response During Laryngoscopy and Intubation","status":"COMPLETED","sponsor":"Dr. Waseem Ullah","startDate":"2024-03-01","conditions":"Hemodynamic Response to Laryngoscopy and Orotracheal Intubation","enrollment":107},{"nctId":"NCT05158387","phase":"PHASE3","title":"Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2022-02-07","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1172}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":50,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"marketed","status":"active","brandName":"Placebo equivalent","genericName":"Placebo equivalent","companyName":"Hospital Civil de Guadalajara","companyId":"hospital-civil-de-guadalajara","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo equivalent produces no pharmacological effect and serves as an inert control in clinical research and therapeutic contexts. Used for Clinical trial control comparator (non-therapeutic use).","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:59:32.585438+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}